MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.8B
Enterprise Value 31.93B
Trailing P/E 87.15
Forward P/E 113.03
PEG Ratio (5 yr expected) 11.74
Price/Sales (ttm)2.09
Price/Book (mrq)1.66
Enterprise Value/Revenue 32.25
Enterprise Value/EBITDA 616.46

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 2.45%
Operating Margin (ttm)5.57%

Management Effectiveness

Return on Assets (ttm)2.15%
Return on Equity (ttm)2.06%

Income Statement

Revenue (ttm)858.5M
Revenue Per Share (ttm)11.82
Quarterly Revenue Growth (yoy)18.30%
Gross Profit (ttm)595.4M
EBITDA 117.5M
Net Income Avi to Common (ttm)21M
Diluted EPS (ttm)0.28
Quarterly Earnings Growth (yoy)-24.20%

Balance Sheet

Total Cash (mrq)149.7M
Total Cash Per Share (mrq)2.04
Total Debt (mrq)263.4M
Total Debt/Equity (mrq)24.35
Current Ratio (mrq)3.15
Book Value Per Share (mrq)14.74

Cash Flow Statement

Operating Cash Flow (ttm)100.1M
Levered Free Cash Flow (ttm)111.85M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.08
52-Week Change 3-35.71%
S&P500 52-Week Change 34.92%
52 Week High 350.44
52 Week Low 323.93
50-Day Moving Average 330.49
200-Day Moving Average 330.65

Share Statistics

Avg Vol (3 month) 3887.38k
Avg Vol (10 day) 31.01M
Shares Outstanding 573.37M
Float 68.59M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Apr 30, 2019) 415.58M
Short Ratio (Apr 30, 2019) 428.14
Short % of Float (Apr 30, 2019) 428.92%
Short % of Shares Outstanding (Apr 30, 2019) 421.22%
Shares Short (prior month Mar 29, 2019) 416.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A